Evidence map›Paper›PMID 33162768›Full record

ReviewDialogues in clinical neuroscience2020

Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
.

Paul D Morrison, Robin M Murray

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Dialogues in clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Acute effects of ΔPsychopharmacology · 2022
    Trial
  2. Exploring causal mechanisms of psychosis risk.Neuroscience and biobehavioral reviews · 2024
    Review
  3. Correction to: The Potential Proconvulsant Effects of Cannabis: a Scoping Review.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2023
    Article
  4. Review
  5. The Potential Proconvulsant Effects of Cannabis: a Scoping Review.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Paul D MorrisonThe Argyll Bute Hospital, Lochgilphead, NHS Highland, Scotland, UK; The Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Robin M MurrayThe Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Argyll and Bute Hospital · GBKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis can elicit an acute psychotic reaction, and its long-term use is a risk factor for schizophrenia. The main active psychoactive ingredient ∆

Indexed as

CannabisAnimalsDronabinolHallucinogensHumansMental DisordersMental ProcessesReceptor, Cannabinoid, CB1SynapsesDronabinolHallucinogensReceptor, Cannabinoid, CB1∆9-tetrahydrocannabinolbipolarcannabiscognitionconnectomedendritic spineketamineplasticitypsychosisschizophrenia

Identifiers

PMID33162768
PMCPMC7605021
OpenAlexW3100973505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.